I. Kusaka et al., Immunologically-related or incidental coexistence of diabetes mellitus andGraves' disease; Discrimination by anti-GAD antibody measurement, ENDOCR J, 46(6), 1999, pp. 747-754
Coexistence of diabetes mellitus and Graves' disease may be classified into
either an immunologically-related or an incidental phenomenon. It has been
reported that anti-GAD antibody (GAD-Ab) persists at high levels for longe
r duration in subjects with type 1 diabetes and Graves' disease, whereas th
e prevalence of positive GAD-Ab (1.5%) in 131 non-diabetic subjects with Gr
aves' disease was comparable to that in normal subjects (0.3%, P=0.2012). T
hus, GAD-Ab might be a marker of the immunologically-related coexistence of
the two diseases. To test this hypothesis, we investigated characteristics
of Japanese subjects having both diseases according to the presence or abs
ence of GAD-Ab. Sixty-one patients having diabetes mellitus and Graves' dis
ease (24 men, 37 women, aged 53+/-2 years old, mean+/-SE) were consecutivel
y registered between 1993-1997. The patients were divided into two groups o
f 14 GAD-Ab positive and 47 negative subjects. In the GAD-Ab positive subje
cts, earlier (32+/-3 years old) and abrupt onset (86%) of diabetes and insu
lin dependency (64%) were documented, as would be expected from the feature
s of type 1 diabetes. Graves' disease often preceded diabetes (57%), presen
ting typical manifestations (79%). In contrast, older (45+/-2 years old, P=
0.0031) and gradual onset (87%, P<0.0001) of diabetes, non-insulin dependen
cy (74%, P<0.0001), and masked manifestations of Graves' disease (57%, P=0.
0214) were common in the negative subjects. Precedence of diabetes dominate
d in these subjects (43%, P=0.0109). Immunological studies showed less freq
uent HLA-DR 2 locus (0%, P<0.02) in the GAD-Ab positive subjects. There was
also a trend of higher frequency of HLA-DQA1*03 allele and of lower freque
ncy of DQAI*01 allele in these subjects. Allelic frequency of cytotoxic T l
ymphocyte antigen 4 (CTLA-4) differed between the positive and negative sub
jects (P=0.0432). There were distinct clinical and immunological difference
s between the GAD-AI, positive and negative subjects having both diabetes m
ellitus and Graves' disease. The present results indicate that GAD-Ab measu
rement could draw a distinction between the immunologically-related and inc
idental coexistence of the two diseases.